MedPath

Gastric Emptying Using Two Imaging Methods for Those Who Have Undergone POSE2 Weight Loss Procedure

Terminated
Conditions
Weight Loss
Registration Number
NCT04502732
Lead Sponsor
Mayo Clinic
Brief Summary

The purpose of this study is to compare a less invasive breath test against the current standard for assessing gastric (stomach) emptying. The current standard of care is a procedure called Nuclear Scintigraphy of a Solid Meal (NSSM). This study will compare this method to a Gastric Emptying Breath Test (GEBT).

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
5
Inclusion Criteria
  • Subjects must be 22-65 years of age at time of enrollment
  • Subjects must already be consented to 17-007934 or 19-001254
  • Subject must be agreeable and compliant with study requirements, including up to three (baseline, 2 month, and 6 month) visits, as well as undergoing GEBT and NSSM testing.
  • If female, must be post-menopausal, surgically sterile, or agree to practice a form of birth control or abstinence during year of study and have negative serum HCG at screening/baseline
  • Must be willing and able to travel, as needed, to the Investigator's office to complete all routine follow-up visits
Exclusion Criteria
  • Persons presently or soon to be incarcerated
  • Females who are pregnant or suspect they may be pregnant
  • Persons with nicotine and/or alcohol dependence
  • Patients with cognitive impairment that limits their ability to make autonomous decisions
  • Known allergies or sensitivities to study materials (eggs and spirulina)
  • Assessed, by the physician or delegate, that enrollment would not be appropriate

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of T1/2Baseline, 2 months, 6 months

The aim of this study is to compare baseline, early post-procedural (2 month), and delayed post-procedural (6 month) T1/2, as assessed by both GEBT and NSSM, in seven adult subjects with obesity who have underwent an EGRWL procedure.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic in Rochester

🇺🇸

Rochester, Minnesota, United States

Mayo Clinic in Rochester
🇺🇸Rochester, Minnesota, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.